登录 | 注册    关注公众号  
微信公众号
搜索
 > 【CLEC3B】

CLEC3B信息

英文名称:Tenascin
中文名称:肌腱蛋白
靶点别称:Glioma-associated-extracellular matrix antigen,GMEM,Neuronectin,Hexabrachion,Tenascin-C,TN-C,GP 150-225,TNC,Tenascin C,Deafness, Autosomal Dominant 56,Hexabrachion (Tenascin),Myotendinous Antigen,Cytotactin,HXB,JI,TN,Hexabrachion (Tenascin C, Cytotactin),Tenascin-C Additional Domain 1,Tenascin-C Isoform 14/AD1/16,150-225,DFNA56,GP,Tenascin,MGC167029
上市药物数量:0
临床药物数量:1
最高研发阶段:终止

CLEC3B产品列表

货号 物种 产品描述 蛋白结构 纯度 活性
 
评论(0)
 

CLEC3B 分子别名

CLEC3B,Tetranectin,TN,TNA

CLEC3B 分子背景

C-type lectin domain family 3 member B (CLEC3B) is also known as Tetranectin, Plasminogen kringle 4-binding protein, is a secreted homotrimer. CLEC3B contains 1 C-type lectin domain and mainly found in plasma. Tetranectin / CLEC3B binds to plasminogen and to isolated kringle 4. CLEC3B may be involved in the packaging of molecules destined for exocytosis. Decreased plasma Tetranectin or increased Tetranectin in stroma of cancers correlates with cancer progression and adverse prognosis.

CLEC3B 前沿进展

CLEC3B临床药物信息

英文名称 研发代码 研发阶段 公司 适应症 临床试验

消息提示

请输入您的联系方式,再点击提交!

确定